Antibiotics Aren’t Profitable Enough for Big Pharma to Make More
Hands wearing blue surgical gloves hold brightly coloured pharmaceutical medication, including antibiotics, paracetamol, Ibuprofen and cold relief tablets, manufactured by a variety of companies in this arranged photograph in London, U.K. (Photographer: Chris Ratcliffe/Bloomberg)

Antibiotics Aren’t Profitable Enough for Big Pharma to Make More

(Bloomberg Businessweek) -- Achaogen Inc. spent 15 years racing to develop antibiotics against resistant superbugs. It targeted one of the most-feared superbugs lurking in intensive care units: car...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.